Evidence map›Paper›PMID 28921494›Full record

ArticleCurrent protocols in nucleic acid chemistry2017

Solid-Phase Synthesis of RNA Analogs Containing Phosphorodithioate Linkages.

Xianbin Yang

Abstract read
In one paragraph

Article in Current protocols in nucleic acid chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. A P(V) platform for oligonucleotide synthesis.Science (New York, N.Y.) · 2021
    Article
  3. Review
  4. Synthesis of 5'-Thiamine-Capped RNA.Molecules (Basel, Switzerland) · 2020
    Article
  5. One Way Traffic: Base-to-Backbone Hole Transfer in Nucleoside Phosphorodithioate.Chemistry (Weinheim an der Bergstrasse, Germany) · 2020
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Xianbin YangAM Biotechnologies, Houston, Texas.
Raptamer Discovery Group (United States) · US

Funding

New Reagents for Synthesis of High Potency siRNAR44GM084552 · NIGMS · AM BIOTECHNOLOGIES, LLC · PI EVERS, BERNARD MARK, SOOD, ANIL K · 2010 to 2011
$949k
New Reagents for Synthesizing Nuclease-resistant siRNAR43GM084552 · NIGMS · AM BIOTECHNOLOGIES, LLC · PI EVERS, BERNARD MARK, YANG, XIANBIN · 2008 to 2009
$199k
NIGMS NIH HHS R43 GM084552NIGMS NIH HHS R44 GM084552
6 · The paper itself

Abstract

The oligoribonucleotide phosphorodithioate (PS2-RNA) modification uses two sulfur atoms to replace two non-bridging oxygen atoms at an internucleotide phosphorodiester backbone linkage. Like a natural phosphodiester RNA backbone linkage, a PS2-modified backbone linkage is achiral at phosphorus. PS2-RNAs are highly stable to nucleases and several in vitro assays have demonstrated their biological activity. For example, PS2-RNAs silenced mRNA in vitro and bound to protein targets in the form of PS2-aptamers (thioaptamers). Thus, the interest in and promise of PS2-RNAs has drawn attention to synthesizing, isolating, and characterizing these compounds. RNA-thiophosphoramidite monomers are commercially available from AM Biotechnologies and this unit describes an effective methodology for solid-phase synthesis, deprotection, and purification of RNAs having PS2 internucleotide linkages. © 2017 by John Wiley & Sons, Inc.

Indexed as

Solid-Phase Synthesis TechniquesOligonucleotidesPhosphatesRNAOligonucleotidesPhosphatesphosphorodithioic acidRNAphosphorodithioate oligoribonucleotidePS2-RNAsolid-phase synthesissulfur-modified oligonucleotidethiophosphoramidite

Identifiers

PMID28921494
PMCPMC5657504
OpenAlexW2758504725

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.